| Literature DB >> 30700785 |
Tyler M Weaver1, Jiachen Liu1, Katelyn E Connelly2, Chris Coble1, Katayoun Varzavand1, Emily C Dykhuizen2, Catherine A Musselman3.
Abstract
SANT domains are found in a number of chromatin regulators. They contain approximately 50 amino acids and have high similarity to the DNA binding domain of Myb related proteins. Though some SANT domains associate with DNA others have been found to bind unmodified histone tails. There are two SANT domains in Enhancer of Zeste 2 (EZH2), the catalytic subunit of the Polycomb Repressive Complex 2 (PRC2), of unknown function. Here we show that the first SANT domain (SANT1) of EZH2 is a histone binding domain with specificity for the histone H4 N-terminal tail. Using NMR spectroscopy, mutagenesis, and molecular modeling we structurally characterize the SANT1 domain and determine the molecular mechanism of binding to the H4 tail. Though not important for histone binding, we find that the adjacent stimulation response motif (SRM) stabilizes SANT1 and transiently samples its active form in solution. Acetylation of H4K16 (H4K16ac) or acetylation or methylation of H4K20 (H4K20ac and H4K20me3) are seen to abrogate binding of SANT1 to H4, which is consistent with these modifications being anti-correlated with H3K27me3 in-vivo. Our results provide significant insight into this important regulatory region of EZH2 and the first characterization of the molecular mechanism of SANT domain histone binding.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30700785 PMCID: PMC6353875 DOI: 10.1038/s41598-018-37699-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Structural characterization of EZH2 SRM-SANT1. (a) The domain architecture of human EZH2. The SRM and SANT1 domain are encased in a dotted black box. The domain architecture of SANT1 and SRM-SANT1 constructs used are shown below. (b) An 1H-15N HSQC spectrum of SANT1 (left) and SRM-SANT1 (right). (c) Secondary structure propensity of SRM-SANT1 determined by TALOS+. The predicted secondary structure propensity is shown as a function of residue, ranging between 0 and 1. All predicted secondary structure was alpha helical. * indicates residues with no CO resonance. (d) The TALOS+ determined RCI-S2 order parameter is shown as a function of residue number where 0 indicates disordered and 1.0 indicates ordered. * indicates residues with no CO resonance.
Figure 2SANT1 is a histone reader domain specific for the H4 tail. (a) 1H-15N HSQC overlay of SRM-SANT1 in the presence of increasing concentrations of H2A (1–20, red), H2B (1–11, green), H3 (1–21, orange), H3 (21–44, orange) and H4 (1–21, blue). Molar ratio of ligand added is indicated in the legend. (b–d) All binding curves used to calculate the Kd for (b) H2A (1–20) peptide, (c) H2B (1–11) peptide, or (d) H4 (1–21) peptide. (e) Table of Kds for all histone tail peptides tested. Underdetermined Kd values due to lack of saturation are given as lower limits, the H4 value is the average over all significant CSPs and associated standard deviation, NB is no binding.
Figure 3SANT1 provides sensitivity to the modification state of the histone H4 tail. (a) Normalized chemical shift perturbation (Δδ) in the 1H-15N HSQC of 15N-SRM-SANT1 between apo and H4-bound as a function of EZH2 residue. TALOS+ predicted secondary structure is shown above. Residues with significant chemical shift perturbation greater than 1.0 and 1.5 standard deviations are labeled with cyan and blue, respectively. Unassigned residues are indicated with *. Prolines are denoted with #. Resonances that broaden beyond detection are labeled with a colored circle. (b) Residues with significant CSPs are highlighted as sticks on a cartoon representation of SANT1 (coordinates taken from 5HYN, the α1-α2 loop and SRM are shown as dashed lines). Residues with significant CSPs are colored as in (a). (c) A HADDOCK model of the SANT1-H4 tail interaction. The histone H4 tail is colored blue and shown as sticks, and the SANT1 domain is shown as a grey cartoon, with interacting residues shown as sticks. SANT1 amino acids are labeled in black using the one-letter code and histone residues are labeled in blue using the three-letter code. (d) 1H-15N HSQC overlay of SRM-SANT1 in the presence of increasing concentrations of H4(11–21) confirms binding to the basic patch of H4 (e) Representative biotin-tagged histone peptide pulldown experiments using purified SRM-SANT1 detected by coomassie staining (top, see Supplementary Fig. S9 for full gel). Unmodified or singly modified histone peptides were tested as denoted above the blot. Quantification of three peptide pulldown experiments (bottom). Binding for each modified peptide is compared to the corresponding unmodified control histone peptide. *Denotes significant differences between modified peptides as determined by p-value < 0.05. (f) 1H-15N HSQC overlay of SRM-SANT1 in the presence of increasing concentrations of H4K16ac(1–21) confirms that acetylation of K16 abrogates binding. (g) Venn diagrams representing the overlap of H3K27me3 with H4 modifications determined from ChIP-Seq data from IMR90 lung fibroblasts. Shown is the comparison of H3K27me3 with H4K16ac (top) or H4K20me3 (bottom).